NO DEBATING REVENUES
For the three and nine months ended April 30, 2012 the Company had revenues of $16,010 and $119,158 consisting of sales to customers of the Company’s surgical implant products.
COSTS OF REVENUES
For the three and nine months ended April 30, 2012 the Company had costs of revenues of $5,841 and $67,242 related to the costs of our surgical implant products sold during the respective periods.
46% PROFIT MARGIN
SGLN
